Performance and Safety of Transfemoral TAVI With SAPIEN XT in Australian Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: SOLACE–AU Trial

2020 ◽  
Vol 29 (12) ◽  
pp. 1839-1846
Author(s):  
Gerald Yong ◽  
Tony Walton ◽  
Martin Ng ◽  
Ronen Gurvitch ◽  
Stephen Worthley ◽  
...  
2019 ◽  
Vol 87 (4) ◽  
pp. 310-312
Author(s):  
Federico Blanco ◽  
Rodrigo Blanco ◽  
Mauricio Bonet ◽  
Gustavo Iralde ◽  
Mariano Campeni ◽  
...  

Author(s):  
Stephanie K. Whitener ◽  
Loren R. Francis ◽  
Jeffrey D. McMurray ◽  
George B. Whitener

The patient with severe asymptomatic aortic stenosis presenting for elective noncardiac surgery poses a unique challenge. These patients are not traditionally offered surgical aortic valve replacement or transcatheter aortic valve replacement given their lack of symptoms; however, they are at increased risk for postsurgical complications given the severity of their aortic stenosis. The decision to proceed with elective noncardiac surgery should be based on individual and surgical risk factors. However, severity of aortic stenosis is not accounted for in current surgical risk factor assessment scoring; therefore, extensive communication with patients and surgical teams is necessary to minimize a patient’s risk. A clear intraoperative plan should be designed to manage the unique hemodynamics of these patients, and a discussion should address postoperative placement.


2018 ◽  
Vol 11 (12) ◽  
pp. 1188-1198 ◽  
Author(s):  
Suzanne J. Baron ◽  
Vinod H. Thourani ◽  
Susheel Kodali ◽  
Suzanne V. Arnold ◽  
Kaijun Wang ◽  
...  

Author(s):  
Joel D. Graham ◽  
M. Keith Sharp ◽  
Steven C. Koenig ◽  
Guruprasad Giridharan ◽  
Michael A. Sobieski ◽  
...  

Treatment of aortic stenosis through surgical replacement has been one of the most successful advances in cardiovascular medicine (1), though use in certain patient populations, specifically in the elderly, has been associated with increased mortality rates (2). A growing alternative surgery is Aortic Valve Bypass (AVB). This therapy offers decreased surgical risk because it does not require cardiopulmonary bypass, aortic crossclamping, aortotomy, or cardioplegic cardiac arrest (3). A one-way conduit between the apex of the left ventricle and the descending aorta increases flow by reducing afterload (Fig. 1, LEFT). Systolic blood from the left ventricle is ejected via both the native stenotic aortic valve and the AVB circuit. In this feasibility study, an apical cannula was developed and tested.


2011 ◽  
Vol 12 (3) ◽  
pp. e27
Author(s):  
Danny Dvir ◽  
Abid Assali ◽  
Alexander Sagie ◽  
Eyal Porat ◽  
Yaron Shapira ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document